Doximity Investor Day Presentation Deck
NEW VERTICAL VIDEO OFFERINGS
doximity
9:41
Sponsored by Doxlera
SUPERIOR relative risk reduction in 3-month CDP vs place
39%
relative risk reduction with
DOXANTIN (db(n-1051)
vs placebo (n-10677
Waiting for
Patient to Join
ann, Elbasanded by a
of c
0:13 View Important Safety Information below, including Bloed Warning
Important Safety Information
Doxlera (doxaterol) injection is indicated as an
adjunct to standard treatment of cardiovascular
(CV) risk factors. Read the Patient Information
Leaflet if available from your pharmacist before
you start taking apremilast and each time you
Med Guide
Prescribing Info
(415) 555-4567
+
add people mute
stop
1:10
end
Point of Care
<
4:40
Today:
Peter Alperin, MD >
Messages are HIPAA compliant
Peter Alperin, MD
Sponsored by Doxlera
Dear Dr. [LastName]:
It's great to connect with you on Doximity.
I recently presented on treatment options for
patients with a history of hypersensitivity to
doxaterol or nosazone.
Here's a summary of my presentation.
Sincerely,
Peter Alperin, MD
Internal Medicine - Austin, TX
Assistant Professor, UT Dell Medical School
Doximity, Inc. 12/23 JOB CODE
Please do not reply to this message. Replies
to this message are routed to an unmonitored
mailbox.
Add Colleague
Peer to Peer
4:40 PM
DOCS Investor Day June 6, 2023View entire presentation